Last reviewed · How we verify

NCT04736992

HKCFP-HKU Primary Care Morbidity Survey in Hong Kong

Completed Last updated 2 November 2022
What this trial tests

trial testing No intervention involved in Primary Health Care in 49 participants. Completed in 31 August 2022.

Timeline
7 March 2021
Primary endpoint
31 August 2022
31 August 2022

Quick facts

Lead sponsorThe University of Hong Kong
StatusCompleted
Study typeOBSERVATIONAL
Enrollment49
Start date7 March 2021
Primary completion31 August 2022
Estimated completion31 August 2022
Sites1 location across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The University of Hong Kong

Who can join

Eligibility, any sex, with Primary Health Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Information about the health problems of patients presenting in primary care is crucial to understanding the health of the general community for the planning and allocation of health care resources. Practice-based morbidity studies conducted in primary care settings have proven to be helpful in documentation of disease prevalence and for service planning. With the change in morbidity pattern and the aging population, our study will help to inform primary health care policy and guide work force and service planning. Method: This is a prospective practice-based study of health problems presenting in primary care. Doctors who agree to participate in the study will record the health problem and type of management performed in consecutive patient encounters for one of the designated weeks during each season over the course of one year. Analysis: Data collected will be analysed by descriptive statistics, comparison with data from previous morbidity study, and by non-linear mixed effects for factors associated with morbidity and management patterns in primary care. Results: Findings will will 1) provide evidence to support the allocation of resources to continue and to expand primary care initiatives that support the provision of quality chronic disease care in private sector, 2) enable continued surveillance of the morbidity trends in Hong Kong by providing data for comparison with past and future studies, and 3) inform the content of educational curricula for medical and health care students and practitioners to prepare them to better meet the needs of the community.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Morbidity Patterns in Primary Care in Hong Kong: Protocol for a Practice-Based Morbidity Survey.
    Chen JY, Chao D, Wong SY, Tse TYE, et al · · 2022 · cited 1× · PMID 35731566 · DOI 10.2196/37334

Verify or expand the search:

Other trials of No intervention involved

Trials testing the same drug.

Other recruiting trials for Primary Health Care

Currently open trials in the same condition.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04736992.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing